Merrimack Pharmaceuticals News
Most Popular Merrimack Pharmaceuticals Story
Merrimack Pharma scraps IPO
Merrimack Pharmaceuticals' attempt to buck the trend on IPOs ended in failure today. The developer, a 2011 Fierce 15 company, has 5 drugs in the clinic and reportedly scrapped its offering saying Read more...
Latest Headlines
- February 1, 2012
- October 13, 2011
- September 6, 2011
- August 25, 2011
- August 25, 2011
- April 14, 2011
- December 8, 2009
- October 1, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
